Microvascular biodistribution of L19-SIP in angiogenesis targeting strategies

European Journal of Cancer

Volumn 47, Issue 8, 2011, Pages 1276-1284

  Czabanka, Marcus ^a   Parmaksiz, Güliz ^a   Bayerl, Simon H ^a   Nieminen, Melina ^a   Trachsel, Eveline ^b   Menssen, Hans D ^d   Erber, Ralf ^c   Neri, Dario ^b   Vajkoczy, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Philogen SPA   (Italy)

Author keywords

Angiogenesis; Anti angiogenic therapy; Antibody based vascular targeting; Extra domain B of fibronectin; L19 SIP

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTIBODY L19 SIP; CANCER ANTIBODY; CD31 ANTIGEN; SUNITINIB; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL PERMEABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG EXTRAVASATION; EMBRYONAL CARCINOMA STEM CELL; GLIOMA; HEMODYNAMICS; HISTOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKINFOLD; TUMOR ANGIOGENESIS;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HUMANS; MICE; MICE, INBRED C57BL; MICROCIRCULATION; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT FUSION PROTEINS; TERATOCARCINOMA;

EID: 79955536635     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.02.001     Document Type: Article

References (23)

1. L. Tarli, E. Balza, and F. Viti A high-affinity human antibody that targets tumoral blood vessels Blood 94 1999 192 198 (Pubitemid 29300149)
2. H. Kosmehl, A. Berndt, and S. Strassburger Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma Br J Cancer 81 1999 1071 1079 (Pubitemid 29516154)
3. L. Borsi, E. Balza, and M. Bestagno Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin Int J Cancer 102 2002 75 85
4. M. Kaspar, E. Trachsel, and D. Neri The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis Cancer Res 67 2007 4940 4948 (Pubitemid 46910202)
5. M.T. Birchler, D. Milisavlijevic, and M. Pfaltz Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors Laryngoscope 113 2003 1231 1237 (Pubitemid 36835572)
6. S. Sauer, P.A. Erba, and M. Petrini Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients Blood 113 2009 2265 2274
7. R.K. Jain Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors Cancer Res 50 1990 814s 819s
8. P. Vajkoczy, L. Schilling, A. Ullrich, P. Schmiedek, and M.D. Menger Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse J Cereb Blood Flow Metab 18 1998 510 520 (Pubitemid 28213535)
9. P. Vajkoczy, M.D. Menger, and B. Vollmar Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy Neoplasia 1 1999 31 41
10. M. Czabanka, M. Vinci, F. Heppner, A. Ullrich, and P. Vajkoczy Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy Int J Cancer 124 2009 1293 1300
11. M. baker, and H. Wayland On-line volume flow rate and velocity profile measurement for blood in microvessels Microvasc Res 7 1974 131 143
12. P. Vajkoczy, M. Farhadi, and A. Gaumann Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2 J Clin Invest 109 2002 777 785 (Pubitemid 34263154)
13. D. Berndorff, S. Borkowski, and D. Moosmayer Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments J Nucl Med 47 2006 1707 1716 (Pubitemid 47545038)
14. E. Balza, L. Mortara, and F. Sassi Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin Clin Cancer Res 12 2006 2575 2582
15. D. Neri, B. Carnemolla, and A. Nissim Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform Nat Biotechnol 15 1997 1271 1275 (Pubitemid 27465138)
16. J. Kaczmarek, P. Castellani, and G. Nicolo Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues Int J Cancer 59 1994 11 16 (Pubitemid 24310940)
17. P. Vajkoczy, and M.D. Menger Vascular microenvironment in gliomas Cancer Treat Res 117 2004 249 262
18. R.K. Jain Antiangiogenic therapy for cancer: current and emerging concepts Oncology (Williston Park) 19 2005 7 16
19. M. Hellstrom, L.K. Phng, and J.J. Hofmann Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis Nature 445 2007 776 780 (Pubitemid 46279716)
20. W. Risau, and V. Lemmon Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis Dev Biol 125 1988 441 450 (Pubitemid 18062480)
21. M. de Jong, and T. Maina Of mice and humans: are they the same?-Implications in cancer translational research J Nucl Med 51 2010 501 504
22. B.L. Coomber, P.A. Stewart, E.M. Hayakawa, C.L. Farrell, and R.F. Del Maestro A quantitative assessment of microvessel ultrastructure in C6 astrocytoma spheroids transplanted to brain and to muscle J Neuropathol Exp Neurol 47 1988 29 40 (Pubitemid 18006102)
23. M.A. Konerding, E. Fait, and C. Dimitropoulou Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study Am J Pathol 152 1998 1607 1616 (Pubitemid 28275018)